Management of allergic rhinitis with leukotriene receptor antagonists versus selective H1-antihistamines: a meta-analysis of current evidence.

Yan FengYa-Ping MengYing-Ying DongChang-Yu QiuLei Cheng

Published in: Allergy, asthma, and clinical immunology : official journal of the Canadian Society of Allergy and Clinical Immunology (2021)

Although both treatments are safe and effective in improving the quality of life (QoL) in AR patients, LTRAs are more effective in improving nighttime symptoms but less effective in improving daytime nasal symptoms compared to SAHs.

Keyphrases

allergic rhinitis
end stage renal disease
sleep quality
ejection fraction
newly diagnosed
chronic kidney disease
peritoneal dialysis
patient reported outcomes
patient reported
chronic rhinosinusitis